10-Q quarterly report · filed Oct 30, 2026

OmniAb, Inc. (OABI) Q3 2026 10-Q Quarterly Report

Short answer

OmniAb, Inc. (OABI) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $4M (up 78.3% year over year) with net income of −$16M.

Q3 2026 key financials · XBRL

Revenue
$4M
+78.3% YoY · −70.2% QoQ
Net income
−$16M
+4.8% YoY · −168.4% QoQ
Operating margin
-409.9%
EPS (diluted)
−$0.12
+14.3% YoY · −140.0% QoQ

Source: XBRL data from the OmniAb, Inc. (OABI) Q3 2026 10-Q on SEC EDGAR. USD.

OmniAb, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $3.993M vs $2.239M, up $1.754M YoY
  • Service revenue $2.835M vs $1.188M, strongest growth from antibody and ion channel programs
  • Q3 net loss $15.728M vs $16.525M, effective tax rate 0.8% vs 6.6%
  • Cash, equivalents and short-term investments $64.2M, sufficient through at least next 12 months
  • Nine-month operating cash flow $8.340M vs $(30.781)M, headwinds from lower platform demand and potential tariffs or trade policies

Risk Factors

  • No material changes to 2025 Annual Report risk factors
  • Carried-forward risk: unknown or currently immaterial factors could materially harm operating results
  • Carried-forward risk: general economic conditions could adversely affect cash flows
  • Carried-forward risk: existing risks could materially weaken financial condition

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other OmniAb, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.